Top Analyst Stock Predictions for Tuesday, Including CrowdStrike's Potential 7% Rise
Dave RamseyRadio host and author promoting debt-free living through his "Baby Steps" program.
Leading financial experts on Wall Street have recently revised their assessments of several key companies. These updated perspectives encompass changes in price targets and overall ratings, reflecting a dynamic outlook on market performance. Investors seeking comprehensive details on these modifications, including both upgrades and downgrades, can access dedicated resources providing a full overview of analyst ratings.
Among the notable revisions, Baird increased the price target for CrowdStrike Holdings Inc. (NASDAQ: CRWD) from $460 to $490, maintaining a Neutral rating. Meanwhile, HC Wainwright & Co. adjusted Fulcrum Therapeutics Inc.'s (NASDAQ: FULC) target down to $3 from $25, changing its rating from Buy to Neutral. Goldman Sachs raised HP Inc.'s (NYSE: HPQ) target from $16 to $19, while still holding a Sell rating. Praxis Precision Medicines Inc. (NASDAQ: PRAX) saw its price target reduced by HC Wainwright & Co. from $1,250 to $1,200, though the Buy rating remained. Ascendiant Capital lifted Genasys Inc.'s (NASDAQ: GNSS) target from $5.50 to $6, reiterating a Buy rating. Conversely, Goldman Sachs significantly lowered Intuit Inc.'s (NASDAQ: INTU) target from $519 to $276, downgrading it to Sell. Evercore ISI Group elevated Guardant Health Inc.'s (NASDAQ: GH) target from $95 to $160, upgrading it to Outperform. Needham raised Credo Technology Group Holding Ltd.'s (NASDAQ: CRDO) target from $220 to $275, keeping a Buy rating. BTIG adjusted Praxis Precision Medicines Inc.'s (NASDAQ: PRAX) target from $843 to $810, maintaining a Buy rating. Lastly, BofA Securities decreased Nu Holdings Ltd.'s (NYSE: NU) target from $16 to $10, downgrading it to Underperform.
These detailed analyst adjustments offer valuable insights for market participants, highlighting shifting expectations for corporate valuations and future stock performance. Such changes underscore the continuous evaluation of company fundamentals and broader economic conditions by financial professionals, aiding investors in making informed decisions and managing their portfolios effectively.
